On Target Laboratories
Ian Laswell has extensive work experience in finance and accounting. Ian currently serves as the VP of Finance at On Target Laboratories. Prior to this, they held the position of Chief Financial Officer at US Bath Group, LLC from April 2018 to October 2021. Ian also worked as the Director of Plant Controller at Boston Scientific from February 2017 to April 2018. From July 2014 to February 2017, Ian Laswell served as the Finance Director (North America) at Ambu A/S. Ian gained experience as the Corporate Controller at King Systems Corporation from February 2012 to June 2014. Ian Laswell's career began at PwC, where they worked as a Senior Associate from September 2003 to April 2005 and as an Assurance Associate from September 2000 to August 2003. Throughout their career, Ian Laswell has showcased their expertise in financial analysis, corporate control, and assurance.
Ian Laswell attended Indiana University - Kelley School of Business from 1996 to 2000, where they obtained a Bachelor of Science degree in Accounting/Finance.
This person is not in any offices
On Target Laboratories
1 followers
On Target Laboratories, LLC engages in discovering, developing, and commercializing small molecules that target specific pathological cells, when conjugated with fluorescent dyes. It offers folate and other targeting agents that target, lung, uterine, kidney, breast, colon, pancreatic, and prostate cancer cells. The company was incorporated in 2010and is based in Northbrook, Illinois.